ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,600,000 | -8.4% | 3,000,000 | 0.0% | 0.19% | +16.4% |
| Q1 2022 | $3,930,000 | -25.6% | 3,000,000 | 0.0% | 0.16% | +15.4% |
| Q4 2021 | $5,280,000 | -18.9% | 3,000,000 | 0.0% | 0.14% | -2.1% |
| Q3 2021 | $6,510,000 | -38.0% | 3,000,000 | 0.0% | 0.15% | -31.5% |
| Q2 2021 | $10,500,000 | -55.6% | 3,000,000 | +25.0% | 0.21% | -49.0% |
| Q1 2021 | $23,664,000 | -12.7% | 2,400,000 | -4.0% | 0.42% | -28.2% |
| Q4 2020 | $27,100,000 | +46.2% | 2,500,000 | +38.9% | 0.58% | +29.3% |
| Q3 2020 | $18,540,000 | -1.3% | 1,800,000 | +100.0% | 0.45% | -14.4% |
| Q2 2020 | $18,792,000 | +220.6% | 900,000 | +50.0% | 0.53% | +112.1% |
| Q1 2020 | $5,862,000 | +142.2% | 600,000 | +50.0% | 0.25% | +293.7% |
| Q3 2018 | $2,420,000 | +14.2% | 400,000 | 0.0% | 0.06% | +40.0% |
| Q2 2018 | $2,120,000 | -8.6% | 400,000 | 0.0% | 0.04% | +55.2% |
| Q1 2018 | $2,320,000 | – | 400,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |